BNP Paribas Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,593
Closed -$1.9M 827
2019
Q3
$1.9M Sell
1,593
-4,429
-74% -$6.76M 0.01% 602
2019
Q2
$9.92M Sell
6,022
-20
-0.3% -$34.6K 0.08% 298
2019
Q1
$12.3M Buy
6,042
+1,512
+33% +$2.66M 0.1% 248
2018
Q4
$5.7M Sell
4,530
-653
-13% -$1M 0.05% 416
2018
Q3
$9.8M Buy
5,183
+721
+16% +$1.49M 0.08% 339
2018
Q2
$9.07M Buy
+4,462
New +$10.2M 0.08% 353
2016
Q2
Sell
-4,793
Closed -$2.64M 1088
2016
Q1
$2.64M Sell
4,793
-537
-10% -$330K 0.02% 615
2015
Q4
$4.43M Buy
5,330
+651
+14% +$650K 0.04% 490
2015
Q3
$5.18M Sell
4,679
-726
-13% -$1.32M 0.05% 458
2015
Q2
$11.8M Sell
5,405
-2,908
-35% -$5.92M 0.1% 295
2015
Q1
$13M Sell
8,313
-2,029
-20% -$2.68M 0.1% 284
2014
Q4
$12.3M Buy
+10,342
New +$6.91M 0.1% 261

Other funds holding BLUE

BNP Paribas Asset Management's BLUE Position: Q4 2019 in Review

BNP Paribas Asset Management sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 1,593 shares — an estimated $1.9M sold.

BNP Paribas Asset Management first reported a position in BLUE in Q4 2014 and held it in 12 quarters. The position peaked at $13M in Q1 2015. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.

  • BNP Paribas Asset Management reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
  • BNP Paribas Asset Management sold 1,593 bluebird bio shares in Q4 2019, an estimated $1.9M.
  • BNP Paribas Asset Management first reported a position in bluebird bio in Q4 2014 and held it in 12 quarters.
  • BNP Paribas Asset Management's bluebird bio position peaked at $13M in Q1 2015.
  • 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.

Based on BNP Paribas Asset Management's 13F filing for Q4 2019, filed 11 Feb 2020.